2.1. Study Design and Patients
abnormal placental adhesions, hemorrhage, fibroids, depression, diabetes
SYSTEMIC DISEASE, COAGULATION DEFECTS, THYROID DYSFUNCTION, HEMORRHAGE, FIBROIDS, PLACENTA PREVIA, HYPERTENSION, DIABETES
This research was carried out at Pamukkale University Hospital Gynecology and Obstetrics Clinic (Denizli, Turkey) between 15 December 2021 and 15 October 2022. The research protocol was approved by the Faculty of Medicine of Pamukkale University Ethics Committee (14 December 2021; 22).All the cases participating in the study had previous cesarean deliveries, were 38–40 weeks pregnant, and planned for cesarean section under elective conditions. Pregnant women with systemic diseases, such as hypertension, diabetes, thyroid dysfunction, and major depression, as well as women with conditions that increase the risk of hemorrhage (such as multiple pregnancies, coagulation defects, fibroids, and abnormal placental adhesions, such as placenta previa) were excluded from the study (The cases (Group 1 (Group 2 (